Hypertension in Chronic Kidney Disease: Novel Insights

Area of Science:

• Nephrology
• Cardiology
• Hypertension Research

Background:

• Arterial hypertension is prevalent in chronic kidney disease (CKD), increasing cardiovascular disease (CVD) and CKD progression risks.
• Aggressive blood pressure (BP) management in CKD patients reduces CVD and mortality, yet renal protection/harm remains debated.
• Abnormal BP patterns in CKD patients occur outside clinical settings, necessitating research into ambulatory vs. office BP monitoring.

Purpose of the Study:

• To review the complexities of managing arterial hypertension in CKD patients.
• To discuss the current understanding and controversies surrounding BP lowering effects on renal outcomes.
• To highlight emerging research areas including renal denervation, microRNAs, and gut microbiota in CKD and hypertension.

Main Methods:

• Review of clinical trials and meta-analyses on hypertension management in CKD.
• Analysis of studies comparing home and ambulatory BP monitoring with clinical outcomes.
• Discussion of current therapeutic strategies and future research directions.

Main Results:

• Aggressive hypertension treatment in CKD lowers CVD and mortality risk.
• Renal effects of BP lowering remain controversial.
• Ambulatory BP monitoring may offer insights into abnormal BP patterns in CKD.
• Renin-angiotensin system blockade benefits are noted, but discontinuation may be needed in specific cases.
• Renal denervation, microRNAs, and gut microbiota are areas for future research.

Conclusions:

• Hypertension management in CKD requires careful consideration of BP targets and monitoring methods.
• Further research is needed to clarify renal protection strategies and the role of novel therapeutic targets.
• Individualized treatment approaches considering BP variability and potential harms are crucial for CKD patients.